Concepedia

Author

Yongxiang Xia

Nanjing Medical UniversityORCID

Also Known As

Changxian Li, Xia Yongxiang, Yong-Xiang Xia, Yong-xiang Xia, Yongxiang Xia

83

Publications

3.2K

Citations

27

H-Index

46

Concepts

All Affiliations

Nanjing Medical UniversityJiangsu Province HospitalChinese Academy of Medical Sciences & Peking Union Medical CollegeSoochow UniversityNanjing University
YX

About

Yongxiang Xia is an author at Nanjing Medical University specializing in medicine, cell biology, and cell signaling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

12

884

2

Cell Biology

7

7

270

3

Hepatology

6

6

712

4

Immunology

6

6

262

5

Health Sciences

1

1

13

Yongxiang Xia

×

40

Publications

2.8K

Citations

24

H-Index

YearCitations

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng,

The Lancet

2023

415

Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3

Runqiu Jiang, Zhongming Tan, Lei Deng,

Hepatology

2011

299

Plasma mi<scp>RNA</scp>s as early biomarkers for detecting hepatocellular carcinoma

Yang Wen, Jing Han, Jianguo Chen,

International Journal of Cancer

2015

215

Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes

Gu‐Wei Ji, Yu‐Dong Zhang, Hui Zhang,

Radiology

2018

201

Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial

Yongxiang Xia, Weiwei Tang, Xiaofeng Qian,

Journal for ImmunoTherapy of Cancer

2022

192

Defective mitophagy in aged macrophages promotes mitochondrial DNA cytosolic leakage to activate STING signaling during liver sterile inflammation

Weizhe Zhong, Zhuqing Rao, Jian Xu,

Aging Cell

2022

150

A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma

Gu‐Wei Ji, Feipeng Zhu, Yu‐Dong Zhang,

European Radiology

2019

145

Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma

Liren Zhang, Jiali Xu, Suiqing Zhou,

Journal of Hepatology

2023

120

PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells

Qing Li, Liren Zhang, Wenhua You,

Nature Communications

2022

109

m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression

Dawei Rong, Fan Wu, Lu Chen,

Molecular Therapy — Nucleic Acids

2021

86

Page 1